These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31014245)

  • 61. KSFinder-a knowledge graph model for link prediction of novel phosphorylated substrates of kinases.
    Anandakrishnan M; Ross KE; Chen C; Shanker V; Cowart J; Wu CH
    PeerJ; 2023; 11():e16164. PubMed ID: 37818330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
    Bonanno L; Pavan A; Ferro A; Calvetti L; Frega S; Pasello G; Aprile G; Guarneri V; Conte P;
    Oncologist; 2020 Dec; 25(12):e1996-e2005. PubMed ID: 32557976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers.
    Xia P; Zhang L; Li P; Liu E; Li W; Zhang J; Li H; Su X; Jiang G
    J Transl Med; 2021 Jul; 19(1):308. PubMed ID: 34271921
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome.
    Sueca-Comes M; Rusu EC; Grabowska AM; Bates DO
    Pharmacol Rev; 2022 Oct; 74(4):1136-1145. PubMed ID: 36180110
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Feasibility and clinical utility of a pan-solid tumor targeted RNA fusion panel: A single center experience.
    Hindi I; Shen G; Tan Q; Cotzia P; Snuderl M; Feng X; Jour G
    Exp Mol Pathol; 2020 Jun; 114():104403. PubMed ID: 32061944
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative kinome analysis to identify putative colon tumor biomarkers.
    Hennig EE; Mikula M; Rubel T; Dadlez M; Ostrowski J
    J Mol Med (Berl); 2012 Apr; 90(4):447-56. PubMed ID: 22095101
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The wild strawberry kinome: identification, classification and transcript profiling of protein kinases during development and in response to gray mold infection.
    Liu H; Qu W; Zhu K; Cheng ZM
    BMC Genomics; 2020 Sep; 21(1):635. PubMed ID: 32928117
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
    Pecciarini L; Brunetto E; Grassini G; De Pascali V; Ogliari FR; Talarico A; Marra G; Magliacane G; Redegalli M; Arrigoni G; Lazzari C; Gregorc V; Bulotta A; Doglioni C; Cangi MG
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190044
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcriptome Sequencing: RNA-Seq.
    Zhang H; He L; Cai L
    Methods Mol Biol; 2018; 1754():15-27. PubMed ID: 29536435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors.
    Joisa CU; Chen KA; Berginski ME; Golitz BT; Jenner MR; Herrera Loeza G; Yeh JJ; Gomez SM
    PeerJ; 2023; 11():e16342. PubMed ID: 38025707
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kinome inhibition states and multiomics data enable prediction of cell viability in diverse cancer types.
    Berginski ME; Joisa CU; Golitz BT; Gomez SM
    PLoS Comput Biol; 2023 Feb; 19(2):e1010888. PubMed ID: 36809237
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions.
    Li B; Qu H; Zhang J; Pan W; Liu M; Yan X; Huang X; He X; Lin D; Liu S; Guan R; Wu Y; Ou Q; Bao H; Xu Y; Wu X; Shao Y; Lin N
    NPJ Precis Oncol; 2021 Sep; 5(1):81. PubMed ID: 34508169
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
    Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
    Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inverse in silico-in vitro fishing of unexpected paroxetine kinase targets from tumor druggable kinome.
    Zhou W; Yang H; Wang H
    J Mol Model; 2020 Jul; 26(8):197. PubMed ID: 32623519
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of kinase gene expression patterns across 5681 human tissue samples reveals functional genomic taxonomy of the kinome.
    Kilpinen S; Ojala K; Kallioniemi O
    PLoS One; 2010 Dec; 5(12):e15068. PubMed ID: 21151926
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy.
    Cheng F; Jia P; Wang Q; Zhao Z
    Oncotarget; 2014 Jun; 5(11):3697-710. PubMed ID: 25003367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomics.
    Guo L; Xiao Y; Fan M; Li JJ; Wang Y
    J Proteome Res; 2015 Jan; 14(1):193-201. PubMed ID: 25341124
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts.
    Lee JH; Gao C; Peng G; Greer C; Ren S; Wang Y; Xiao X
    Circ Res; 2011 Dec; 109(12):1332-41. PubMed ID: 22034492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Soybean kinome: functional classification and gene expression patterns.
    Liu J; Chen N; Grant JN; Cheng ZM; Stewart CN; Hewezi T
    J Exp Bot; 2015 Apr; 66(7):1919-34. PubMed ID: 25614662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.